DAN A22
Pill imprint DAN A22 has been identified as Ranitidine HCl 150 MG.
Ranitidine is used in the treatment of stomach ulcer; gerd; gastric ulcer maintenance treatment; indigestion; erosive esophagitis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Ranitidine 150 MG is not subject to the Controlled Substances Act.
See also related documents.
Ranitidine HCl Images
- Imprint:
-
DAN A22
- Strength:
- 150 MG
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Schein
Advertisement
More RANITIDINE HCL resources
- Ranitidine
- Ranitidine (Wolters Kluwer)
- Ranitidine Effervescent Tablets (Wolters Kluwer)
- Ranitidine Syrup (Wolters Kluwer)
- Ranitidine Tablets (Wolters Kluwer)
- ranitidine (Cerner Multum)
- Ranitidine Hydrochloride (AHFS DI)
- Acid Reducer Drug Facts (FDA)
- Acid Relief (FDA)
- Formucare Ranitidine (FDA)
- Good Neighbor Acid Control (FDA)
- Heartburn Relief Drug Facts (FDA)
- Leader Acid Control (FDA)
- Maximum Strength Acid Control Drug Facts (FDA)
- Ranitidine (FDA)
- Ranitidine 75 Drug Facts (FDA)
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
- Sunmark Acid Reducer Ranitidine (FDA)
- Up and Up Acid Reducer (FDA)
- Zantac Cool Mint (FDA)
- Zantac Injection (FDA)
- Ranitidine (Wolters Kluwer)
Search Again
